The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 140, No 11, 1373-1376.
© 2009 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Muñante-Cárdenas, J. L.
Right arrow Articles by de Moraes, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muñante-Cárdenas, J. L.
Right arrow Articles by de Moraes, M.

CLINICAL PRACTICE

Treating Oral Histoplasmosis in an Immunocompetent Patient



José Luis Muñante-Cárdenas, DDS, Adriano Freitas de Assis, DDS, MSc, Sergio Olate, DDS, MSc, Mariana Camilo Negreiros Lyrio, DDS, MSc and Márcio de Moraes, DDS, MSc, PhD

Background. Histoplasmosis is a deep fungus infection that occurs worldwide and is caused by Histoplasma capsulatum. Oral histoplasmosis has been of considerable importance in recent years because it occurs frequently in immunosuppressed patients, more often in those who test positive for the human immunodeficiency virus (HIV). However, the literature contains reports of histoplasmosis in immunocompetent patients, especially in endemic areas.

Case Description. The authors describe a case of an HIV-negative, immunocompetent 60-year-old man with ulcerative and painful oral lesions. The clinician included squamous cell carcinoma and systemic mycosis in the differential diagnosis. After the patient underwent a biopsy and a definitive diagnosis was reached, his initial treatment regimen included itraconazole (200 milligrams per day for one month), nystatin and chlorhexidine mouthrinse (0.12 percent, 10 milliliters, two times a day). The itraconazole treatment was continued for three more months (100 mg daily) until the lesions had resolved completely.

Clinical Implications. Clinicians need to conduct a careful clinical evaluation and make an accurate diagnosis of ulcerated oral lesions. Knowledge of the oral manifestations of histoplasmosis may enable clinicians to reach a diagnosis earlier and initiate therapy more quickly.

Key Words: Oral pathology; fungal infections; oral ulcers; antifungal agents

Abbreviations: HIV: Human immunodeficiency virus • PAS: Periodic acid-Schiff







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2009 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.